1. 2500 Orteronel (Ort) maintenance therapy in patients (pts) with metastatic castration resistant prostate cancer (mCRPC) and non-progressive disease after first-line docetaxel (Doc) therapy: Results of a multicenter randomized double-blind placebo-controlled phase III trial (SAKK 08/11). Issue 3 (September 2015) Authors: Cathomas, R.; Crabb, S.; Kenner, H.; Mark, M.; Rothermundt, C.; Elliott, T.; Winterhalder, R.; Von Burg, P.; Berardi Vilei, S.; Hayoz, S.; Rauch, D.; Roggero, E.; Stenner, F.; Berthold, D.; Erdmann, A.; Fischer, N.; Manetsch, G.; Gillessen, S. Journal: European journal of cancer Issue: Volume 51:Issue 3(2015:Feb.) Page Start: S473 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in Switzerland. Issue 2 (23rd December 2020) Authors: Moccia, A. A.; Aeppli, S.; Güsewell, S.; Bargetzi, M.; Caspar, C.; Brülisauer, D.; Ebnöther, M.; Fehr, M.; Fischer, N.; Ghilardi, G.; Krasniqi, F.; Lang, N.; Mey, U.; Mingrone, W.; Novak, U.; Pfleger, C.; Richter, P.; Rütti, M.; Schmidt, A.; Stenner, F. Journal: Hematological oncology Issue: Volume 39:Issue 2(2021) Page Start: 196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CLINICAL CHARACTERISTICS AND OUTCOME OF PATIENTS WITH HODGKIN'S LYMPHOMA OLDER THAN 60 YEARS TREATED IN SWITZERLAND OVER THE LAST 17 YEARS. (12th June 2019) Authors: Aeppli, S.; Moccia, A.; Bargetzi, M.; Brülisauer, D.; Caspar, C.; Ebnöther, M.; Fehr, M.; Fischer, N.; Ghilardi, G.; Krasniqi, F.; Lang, N.; Mey, U.; Mingrone, W.; Novak, U.; Richter, P.; Rütti, M.; Schmidt, A.; Stenner, F.; Voegeli, M.; Zander, T. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 289 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗